MURFREESBORO, TN - National Health Investors, Inc. (NYSE:NHI), a real estate investment trust specializing in senior housing and medical investments, announced on Tuesday its decision to pay a third-quarter dividend of $0.90 per common share. The dividend is payable on November 1, 2024, to stockholders of record as of September 27, 2024.
The company, incorporated in 1991, has a diverse portfolio that includes independent living, assisted living, memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. National Health Investors focuses on sale-leasebacks, joint ventures, senior housing operating partnerships, and mortgage and mezzanine financing.
In other recent news, National Health Investors Inc . (NHI) has reported a robust first quarter for 2024 and raised its full-year guidance. The company's strong performance was marked by stable cash collections, improving operational fundamentals, and an expected over 5% Funds Available for Distribution (FAD) growth at the midpoint for the year. Truist Securities has increased NHI's stock price target to $65.00, maintaining a Hold rating, reflecting an optimistic view of the company's financial prospects. This includes a robust increase in Senior Housing Operating Properties (SHOP) occupancy rates and the anticipation of higher rental income from an expected lease renewal with National HealthCare Corporation (NHC).
Furthermore, NHI has committed $19 million to Net Operating Income (NOI)-producing CapEx investments and has over $300 million in its pipeline. The company has agreed to a favorable rent increase with Bickford, boosting base rent by 10% annually. Additionally, NHI sold seven properties for $43.7 million and transitioned one property in Wisconsin to another operator. The company has also reported a first-quarter NOI increase in the SHOP segment to $2.9 million. These recent developments indicate a strong position for future expansion in the Senior Housing and skilled nursing sectors.
InvestingPro Insights
National Health Investors, Inc. (NYSE:NHI) continues to demonstrate its commitment to shareholders with its recent announcement of a third-quarter dividend of $0.90 per common share. A notable aspect of NHI's financial health is its consistent history of dividend payments, which have been maintained for 34 consecutive years, a testament to the company's stability and reliability for income-focused investors. This is particularly significant in an industry where the ability to sustain dividend payments can be a strong signal of a company's operational strength and long-term strategy.
From a valuation standpoint, NHI is currently trading at a price-to-earnings (P/E) ratio of 24.53, which aligns with the InvestingPro Tip that the stock is trading at a low P/E ratio relative to its near-term earnings growth. This could suggest that the stock is undervalued in comparison to its growth potential, offering an attractive entry point for value investors. Additionally, the stock has experienced a large price uptick over the last six months, as evidenced by a 43.61% price total return over the period, which may indicate positive investor sentiment and potential momentum.
InvestingPro Data also highlights that NHI has achieved a revenue growth of 10.41% over the last twelve months as of Q1 2024. This growth, coupled with a robust gross profit margin of 96.14% and an operating income margin of 55.48%, underscores the company's efficient management and strong position within the healthcare real estate sector.
For investors seeking more detailed analytics and insights, InvestingPro offers additional tips on National Health Investors, which can be accessed at https://www.investing.com/pro/NHI. These tips can provide further guidance for making informed investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.